You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular and metabolic risk
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

 

Online download statistics by month:

Online download statistics by month: January 2018 to March 2024

AbstractFullPdf
Jan 201811901193329
Feb 20187917781043
Mar 2018850857220
Apr 201829930355
May 201826927456
Jun 201840941171
Jul 201816316226
Aug 201849850029
Sep 201811211239
Oct 201811711631
Nov 201820520539
Dec 201826425946
Jan 201920320027
Feb 201913813615
Mar 201915015033
Apr 2019868617
May 2019676527
Jun 2019686718
Jul 2019484911
Aug 2019515126
Sep 2019656331
Oct 2019787626
Nov 2019474526
Dec 20191068431
Jan 2020595917
Feb 2020686729
Mar 2020363613
Apr 2020535217
May 202059599
Jun 2020585553
Jul 2020494916
Aug 2020524621
Sep 2020494410
Oct 2020545218
Nov 202048489
Dec 2020494614
Jan 202129269
Feb 202151489
Mar 2021636216
Apr 2021575610
May 202159585
Jun 2021424010
Jul 202136359
Aug 2021363518
Sep 202134337
Oct 2021494420
Nov 2021343319
Dec 202139408
Jan 202239398
Feb 202223236
Mar 2022454513
Apr 202235357
May 2022717019
Jun 2022282510
Jul 202253533
Aug 202234346
Sep 2022434213
Oct 2022596014
Nov 2022595812
Dec 2022529221
Jan 202333378
Feb 20231221206
Mar 202339429
Apr 2023373623
May 202327275
Jul 2023373619
Aug 2023414213
Sep 2023505311
Oct 202360639
Nov 2023373412
Dec 2023282911
Jan 202430227
Feb 202452479
Mar 2024585574
Total862985842986